2BB score and signals
Rigel Pharmaceuticals, Inc.’s current 2BB score is 47 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 59 | Moderate |
| Momentum | 62 | Improving |
| Financial strength | 75 | Strong |
| Quality | 97 | Very Strong |
| Risk | 15 | Very Low |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 1996 |
| Employees | 173 |
| P/E ratio | 2.92 |
| 52-week range | $24.95 – $52.06 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-01 | — | 0.7854 | — | $89.88M |
| 2026-11-02 | — | 0.8534 | — | $81.70M |
| 2026-08-04 | — | 0.6324 | — | $70.85M |
| 2026-05-05 | 0.44 | 0.697 | $58.82M | $63.64M |
Related companies
2BBBullish & Bearish